Navigation Links
VacChina 2010 - A Premium Event to Define the Vaccine Industry in Asia

SHANGHAI, June 25 /PRNewswire-Asia/ --

"Life or death for a young child too often depends on whether he is born in a country where the vaccines are available or not."

-- Nelson Mandela

Hosted by Global Leaders Institute, world vaccine industry leaders will convene at VacChina 2010 on Sept 15 and 16 in Shanghai. The two-day executive summit will explore the major partnering opportunities in the vaccine industry in China. The goal of the summit is to bridge the China vaccine industry with the world in terms of vaccine R&D and production innovation and address needs of the entire industry to improve vaccine quality and safety.

At the end of 2009, the vaccine industry raised so much concern worldwide that the headlines of the business media were occupied by various kinds of news about vaccine enterprises. For example, Sinovac Biotech Co., Ltd. successfully landed the Nasdaq, then Simcere, a pharmaceutical company based in Jiangsu Province and listed on the NYSE, announced a 50.8% stake in Ealong Biotech and took control of the latter, and finally Novartis, the world-famous pharmaceutical company headquartered in Switzerland, acquired an 85.0% equity in Tianyuan Bio-Pharmaceutical, a vaccine producer, for RMB850M. These deals indicate that the investors and foreign pharmaceutical giants have not slowed down their pace to enter China's vaccine market, even in the face of this economic recession.

Over 150 attendees from vaccine producers home and abroad will gather under the same roof to elaborate on themes on the evolution of China's vaccine market and make comparisons to other emerging markets. Other topics will include the role of vaccines in the overall healthcare reform efforts in China and associated pricing strategies, future prospects of foreign vaccine products into China's EPI, China's intellectual property landscape, vaccine manufacturing in China, quality and safety from design to operations, bridging the gap between R&D and production, low cost novel purification platforms for vaccine production capacity and quality etc.

Renowned presenters speaking at the main conference on Sept 15 and 16 include Weidong Yin from Sinovac China, Xiaohang Ding from Zhejiang Tianyuan Bio-Pharmaceutical, Bing Zeng from Sinopharm, Xiaohan Du from Simcere Pharmaceutical Group, Pierre Trotemann from Sanofi Pasteur, Shou-Bai Chao from MedImmune, etc.

    For more information, please contact:

     Daniel Chen
     Tel:   +86-21-3251-6046

    Or visit the website

SOURCE Global Leaders Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Myelin Removal Beads: Premium Efficiency for Neural Cell Separations and Antibody Stainings
2. First Osteoporosis Study in Hip Fracture Patients Finds Once-Yearly Reclast(R) Prevents Additional Fractures and Improves Survival
3. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
4. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
5. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
6. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
7. U.S. Preventive Medicine Acquires Specialty Disease Management
8. For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter
9. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
10. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
11. Inhaled Steriods Used as Preventive Treatment Post 9/11
Post Your Comments:
(Date:11/25/2015)... ATLANTA , Nov. 25, 2015 ... the first federal bellwether trial against Wright Medical ... relating to their Conserve metal-on-metal hip implant device, ... Christiansen.  Following a two week trial and three ... Conserve metal-on-metal hip device was defectively designed and ...
(Date:11/25/2015)... , Nov. 25, 2015  Trovagene, Inc. (NASDAQ: ... announced that Chief Executive Officer Antonius Schuh, Ph.D., is ... th Annual Piper Jaffray Healthcare Conference. ... New York Palace Hotel in New York ... p.m. EST. Mr. Schuh will be available for one-on-one ...
(Date:11/25/2015)... --> --> ... was valued at $11,171.1 million in 2014, and it ... during 2015 - 2022. The global market is growing, ... diabetes. In addition, the increase in obese population and ... the growth of the market. Furthermore, technological advancements in ...
Breaking Medicine Technology:
(Date:11/25/2015)... Ill. (PRWEB) , ... November 25, 2015 , ... ... and potentially more aggressive than those found on mammography, according to a study ... findings of additional cancers not seen on mammography may necessitate a change in ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... factory direct sauna parts and accessories. , Sauna accessories help improve the bather ... style and personality. From basic styles for the purist looking for simplicity in ...
(Date:11/25/2015)... , ... November 25, 2015 , ... According to an ... robot is being more and more widely heralded as a breakthrough for performing hernia ... method has over traditional laparoscopic surgery is that it can greatly reduce the pain ...
(Date:11/25/2015)... , ... November 25, 2015 , ... The McHenry County ... recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. Wimmer. ... Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court documents, ...
(Date:11/25/2015)... ... 25, 2015 , ... Brillianteen, McGaw YMCA’s student-produced musical show, ... 65th Anniversary Brillianteen Revue, scheduled for March 4-6, 2016. Auditions for this final ... has been a treasured tradition for numerous families in the Evanston community. Over ...
Breaking Medicine News(10 mins):